Ahmed M Said

Title: Ahmed M Said - Innovator in Pharmaceutical Chemistry

Introduction

Ahmed M Said is a notable inventor based in Cairo, Egypt. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for cancer treatment. His innovative work has the potential to impact therapeutic regimes for breast cancer.

Latest Patents

Ahmed M Said holds a patent for "Aryl-1,2,3-triazole compounds, pharmaceutical composition thereof and method for treatment of breast cancer." This patent describes compounds belonging to the group of N-benzyl-2-(4-(4-substituted-1H-1,2,3-triazol-1-yl)phenylacetamides, which exhibit cytotoxic activities against MCF7 breast cancer cells. These compounds are useful in therapeutic regimes for breast cancer and have beneficial effects on BAX, BCL-2, MCL-1, and MAPK pathways within MCF7 breast cancer cells.

Career Highlights

Throughout his career, Ahmed M Said has worked at prestigious institutions such as the University of Jeddah and King Abdulaziz University. His experience in these academic environments has allowed him to further his research and contribute to advancements in pharmaceutical sciences.

Collaborations

Ahmed has collaborated with notable colleagues, including Roaa M Alreemi and Hind A Alkhatabi. These partnerships have fostered a collaborative environment that enhances research and innovation in the field.

Conclusion

Ahmed M Said is a distinguished inventor whose work in pharmaceutical chemistry is paving the way for new treatments for breast cancer. His contributions are vital to the ongoing fight against this disease, and his innovative spirit continues to inspire others in the field.